Inventor · disambiguated record
Leo A. Kim
Also filed as: KIM LEO · KIM LEO A
8 granted patents·7 pending applications·17 citations·filing 2014–2024
80Inventor score
Top patents by PatentIndex Score
15 records- 0191US10881548B2Methods of delivering an agent to the eyeMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2016·Granted Jan 5, 2021·8 cites·20 claims
- 0287US10906969B2Local orbital therapy for thyroid eye diseaseMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2017·Granted Feb 2, 2021·5 cites·5 claims
- 0383US11229662B2Compositions and methods for the treatment of aberrant angiogenesisSCHEPENS EYE RES INST·Filed 2017·Granted Jan 25, 2022·2 cites·15 claims
- 0474US11739326B2RUNX1 inhibition for treatment of proliferative vitreoretinopathy and conditions associated with epithelial to mesenchymal transitionSCHEPENS EYE RES INST·Filed 2018·Granted Aug 29, 2023·1 cites·33 claims
- 0573US12440443B2Nano-emulsion of CBFβ-RUNX1 inhibitor for ocular drug deliverMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2023·Granted Oct 14, 2025·0 cites·20 claims
- 0671US11583497B2Nano-emulsion of CBFß-RUNX1 inhibitor for ocular drug deliverySCHEPENS EYE RES INST·Filed 2018·Granted Feb 21, 2023·1 cites·6 claims
- 0771US2024390182A1Methods of delivering an agent to the eyeMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2024·Application pending·0 cites
- 0869US2024175022A1RUNX1 Inhibition for Treatment of Proliferative Vitreoretinopathy and Conditions Associated with Epithelial to Mesenchymal TransitionSCHEPENS EYE RES INST·Filed 2023·Application pending·0 cites
- 0967US2022184109A1Compositions and methods for the treatment of aberrant angiogenesisSCHEPENS EYE RES INST·Filed 2021·Application pending·0 cites
- 1065US11963905B2Methods of delivering an agent to the eyeMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2021·Granted Apr 23, 2024·0 cites·18 claims
- 1161US2023355611A1Topotecan for proliferative vitreoretinopathySCHEPENS EYE RES INST·Filed 2023·Application pending·0 cites
- 1258US2025099614A1Nucleic acid encoded transcription factor inhibitorsCureVac SE·Filed 2023·Application pending·0 cites
- 1352US2023190764A1Methods and Materials for Treatment of FibrosisSCHEPENS EYE RES INST·Filed 2021·Application pending·0 cites
- 1449US2023310446A1Rho kinase inhibition for treatment of proliferative vitreoretinopathy and conditions associated with epithelial to mesenchymal transitionSCHEPENS EYE RES INST·Filed 2021·Application pending·0 cites
- 1544US9986905B2Predicting retinal degeneration based on three-dimensional modeling of oxygen concentrationSCHEPENS EYE RES INST·Filed 2014·Granted Jun 5, 2018·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Leo A. Kim files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →